Sponsor or institution

Clinical trials and research at Marengo Therapeutics, Inc.

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Combination treatment for advanced solid tumors using Invikafusp Alfa and Sacituzumab Govitecan

  This study is testing a new combination treatment of Invikafusp Alfa and Sacituzumab Govitecan to see if it helps people with advanced solid tumors, like certain types of breast cancer, feel better.

  Recruiting at 8 sites Phase 1/2 Marengo Therapeutics, Inc. · Los Angeles, California and 7 other locations · NCT06827613

• Treatment with STAR0602 for advanced solid tumors

  This study is testing a new treatment called STAR0602 to see if it can help people with advanced solid tumors by looking at how safe it is and how well it works.

  Recruiting at 16 sites Phase 1/2 Marengo Therapeutics, Inc. · Sacramento, California and 18 other locations · NCT05592626

Quick answers

How many clinical trials run by Marengo Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Canada (2 trials), United States (2 trials), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →